Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 03/31 11:17:37 am
120.52 USD   -0.60%
03/25 VERTEX PHARMACE : Biotech Equities Technical Coverage - ZIOPHARM Onc..
03/23 NASDAQ 100 MOVE : Vrtx, vip
03/23 S&P 500 MOVERS : Vrtx, gnw
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/25/2015 03/26/2015 03/27/2015 03/30/2015 03/31/2015 Date
118.64(c) 117.6(c) 120.34(c) 121.25(c) 120.52 Last
2 429 906 1 902 885 1 618 094 1 263 776 303 214 Volume
-4.58% -0.88% +2.33% +0.76% -0.60% Change
More quotes
Financials ($)
Sales 2015 1 087 M
EBIT 2015 -284 M
Net income 2015 -408 M
Finance 2015 570 M
Yield 2015 -
Sales 2016 2 903 M
EBIT 2016 1 239 M
Net income 2016 1 023 M
Finance 2016 1 790 M
Yield 2016 -
PER 2015 -
PER 2016 33,22
EV / Sales 2015 26,5x
EV / Sales 2016 9,49x
Capitalization 29 353 M
More Financials
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
03/29 VERTEX PHARMACEUTICALS : Updates on Data from 12-Week Phase 2 Safety Study of VX..
03/29 VERTEX PHARMACEUTICALS : Secures U.S. FDA OK of KALYDECO (ivacaftor) for Childre..
03/26 VERTEX PHARMACEUTICALS : Assigned Patent
03/26 VERTEX PHARMACEUTICALS : Reports Data from 12-Week Phase 2 Safety Study of VX-66..
03/25 CHRISTOPHER WRIGHT : Pronutria Biosciences™ Appoints Dr. Christopher Wrigh..
03/25 VERTEX PHARMACEUTICALS : Patent Issued for Systems and Methods for Inline Sampli..
03/25 VERTEX PHARMACEUTICALS : Receives U.S. Food and Drug Administration Approval of ..
03/25 VERTEX PHARMACEUTICALS : Biotech Equities Technical Coverage - ZIOPHARM Oncology..
More news
Sector news : Biopharmaceuticals
09:49a MYLAN NV : Launches Generic Exforge® Tablets
09:47a AUSPEX PHARMACEUTICALS : NASDAQ:ASPX) Investor Alert: Investigation of Takeover ..
09:20a MEDA : publ) Notice of Annual General Meeting 2015
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/23 2015 could be the year of the blockbuster drug
03/23 Vertex Pharma off on trial data for VX-661
03/18 FDA clears Vertex CF drug for use in younger children
03/16 PDUFA date approaches for Kalydeco label expansion
03/13 NEXT WEEK IN BIOTECH : Vertex PDUFA, Organon Ad Comm


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF